Seroprevalence and risk factors associated with herpes simplex virus infection among pregnant women

Journal of Perinatal Medicine

Volumn 36, Issue 3, 2008, Pages 206-212

  Arama, Victoria ^a   Vladareanu, Radu ^b   Mihailescu, Raluca ^a,f   Streinu Cercel, Adrian ^a   Mihai, Carina ^b   Hristea, Adriana ^a   Iosipenco, Mihaela ^a   Stefan Arama, Sorin ^b   Rabilloud, Muriel ^c,d,e  

^a Prof Dr Matei Bals National Institute of Infectious Diseases   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^f Université Lyon I ^*  (Romania)

Author keywords

Herpes simplex virus; Pregnant women; Romania; Seroprevalence

Indexed keywords

IMMUNOGLOBULIN G;

ACADEMIC ACHIEVEMENT; ADOLESCENT; ADULT; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HERPES SIMPLEX VIRUS; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK FACTOR; SEROPREVALENCE; SEXUAL BEHAVIOR; VIRUS INFECTION;

EID: 44949092248     PISSN: 03005577     EISSN: 16193997     Source Type: Journal    
DOI: 10.1515/JPM.2008.046     Document Type: Article

References (30)

1. Beckett LA, Tancredi D. Parametric empirical Bayes estimates of disease prevalence using stratified samples from community populations. Stat Med. 2000;19:681-95.
2. Brown ZA, Selke S, Zeh J, et al. The acquisition of herpes simplex virus during pregnancy. N Engl J Med. 1997;337:509-15.
3. Brown ZA, Gardella C, Wald A, et al. Genital herpes complicating pregnancy. Obstet Gynecol. 2005;106:845-56.
4. Boucher FD, Yasukawa LL, Bronzan RN, Hensleigh PA, Arvin AM, Prober CG. A prospective evaluation of primary genital herpes simplex virus type 2 infections acquired during pregnancy. Pediatr Infect Dis J. 1990;9:499-504.
5. Cowan FM, Johnson AM, Ashley R, Corey L, Mindel A. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. Br Med J. 1994;309:1325-9.
6. Cusini M, Ghislanzoni M. The importance of diagnosing genital herpes. J Antimicrob Chemother. 2001;47(Suppl T1):9-16.
7. Dan M, Sadan O, Glezerman M. Prevalence and risk factors for herpes simplex virus type 2 infection among pregnant women in Israel. Sex Transm Dis. 2003;30:835-8.
8. Eberhart-Phillips J, Dickson NP, Paul C, et al. Herpes simplex type 2 infection in a cohort aged 21 years. Sex Transm Infect. 1998;74:216-8.
9. Fisher R. Genital herpes in pregnancy. Emedicine. 2006 Apr.
10. Fleming D, McQuillan G, Johnson R. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med. 1997;337:1105-11.
11. Gibson JJ, Hornung CA, Alexander GR, et al. A cross-sectional study of herpes simplex virus types 1 and 2 in college students: occurrence and determinants of infection. J Infect Dis. 1990;162:306-12.
12. nd ed. New York: The World Bank and Oxford University Press. 2006. p. 25-45.
13. nd ed. New York: Oxford University Press; 2006.
14. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL. Global burden of disease and risk factors. New York: Oxford University Press; 2006.
15. Nahnias AJ, Lee FK, Beckman-Nahnias S. Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis Suppl. 1990;69:19-36.
16. Obasi A, Mosha F, Quigley M, et al. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis. 1999;179:16-24.
17. Oberle MW, Rosero-Bixby L, Lee FK, Sanchez-Braverman M, Nahmias AJ, Guinan ME. Herpes simplex virus type 2 antibodies: high prevalence in monogamous women in Costa Rica. Am J Trop Med Hyg. 1989;41:224-9.
18. Pebody RG, Andrews N, Brown D, et al. The seroepidemiology of Herpes Simplex Virus type 1 and 2 in Europe. Sex Transm Infect. 2004;80:185-91.
19. Smith JS, Herrero R, Munoz N, Eluf-Neto J, Ngelangel C, Bosch X, et al. Prevalence and risk factors for herpes simplex virus type 2. Infection among middle-age women in Brazil and the Philippines. Sex Transm Dis. 2001;28:187-94.
20. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J Infect Dis. 2002;186(Suppl 1):S3-S8.
21. Stanberry LR, Cunningham AL, Mindel A, Scott LL, Spruance L, Aoki FY, et al. Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis. 2000;30:549-66.
22. Stavraky KM, Rawls WE, Chiavetta J, et al. Sexual and socioeconomic factors affecting the risk of past infections with herpes simplex virus type 2. Epidemiol Rev. 1983;118:109-21.
23. Steben M, Sacks S. Objectifs nationaux en matiere de prevention et de controle des maladies transmises sexuellement au Canada. Can Commun Dis Rep. 1997;23:S6.
24. Tao G, Kassler WJ, Rein DB. Medical care expenditures for genital herpes in the United States. Sex Transm Dis. 2000;27:32-8.
25. Tideman RL, Taylor J, Marks C. Sexual and demographic risk factors for herpes simplex type 1 and 2 in women attending an antenatal clinic. Sex Transm Infect. 2001;77:413-5.
26. Uribe-Salas F, Hernandez-Avila M, Juarez-Figueroa L, et al. Risk factors for herpes simplex virus type 2 infection among female commercial sex workers in Mexico City. Int J STD AIDS. 1999;10:105-11.
27. Wald A, Corey L, Cone R, Hobson A, Davis G, Zeh J. Frequent genital herpes simplex virus 2 shedding in immunocompetent women. Effect of acyclovir treatment. J Clin Invest. 1997;99:1092-7.
28. Wald A, Koutsky L, Ashley RL, Corey L. Genital herpes in a primary care clinic: demographic and sexual correlates of herpes simplex type 2 infections. Sex Transm Dis. 1997;24:149-55.
29. Whitley R. Neonatal herpes simplex virus infections. Curr Opin Infect Dis. 2004;17:243-6.
30. Xu F, Markowitz LE, Gottlieb SL, Berman SM. Seroprevalence of herpes simplex virus types 1 and 2 in pregnant women in the United States. Am J Obstet Gynecol. 2007;196,1:43e1-43e6.